By accurately stratifying patients’ risk and guiding targeted screening and preventative interventions, development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in patients with breast cancer will contribute to improved management and outcomes of HBOC (10). Here, BRCA1 is linked to breast cancer.